ArticleFrontiers in immunology2022

Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.

Roxane Mari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.